Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Myb like, SWIRM and MPN domains 1 | 0.700 | 0.462 | 4.3E-02 |
|
disease | 0.110 | None | < 0.001 | 1 | 1 | 2011 | 2011 | ||||||||
|
heparan sulfate 6-O-sulfotransferase 3 | 0.792 | 0.423 | 0.99 |
|
disease | 0.110 | None | < 0.001 | 1 | 1 | 2011 | 2011 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.110 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
Wnt family member 10A | 0.547 | 0.731 | 4.2E-09 |
|
disease | 0.140 | None | 0.400 | 1 | 1 | 2012 | 2018 | ||||||||
|
MIR137 host gene | 0.839 | 0.038 |
|
disease | 0.460 | None | 0.500 | 9 | 6 | 2011 | 2019 | |||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.470 | None | 0.500 | 3 | 8 | 2002 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 3 | 5 | 1993 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 2694 | 0.780 | 0.308 | 1.7E-02 |
|
disease | 0.420 | None | 0.500 | 3 | 3 | 2008 | 2019 | ||||||||
|
FYN proto-oncogene, Src family tyrosine kinase | 0.556 | 0.731 | 0.99 |
|
disease | 0.450 | None | 0.500 | 2 | 1 | 2000 | 2019 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.110 | None | 0.500 | 2 | 2 | 2018 | 2019 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
disease | 0.450 | None | 0.500 | 2 | 1 | 2008 | 2019 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.410 | None | 0.500 | 1 | 1 | 2013 | 2016 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2011 | 2015 | ||||||||
|
spondin 1 | 0.705 | 0.385 |
|
disease | 0.120 | None | 0.500 | 1 | 1 | 2014 | 2018 | |||||||||
|
MER proto-oncogene, tyrosine kinase | 0.531 | 0.692 | 2.7E-11 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2012 | 2017 | ||||||||
|
adenosine deaminase RNA specific B2 (inactive) | 0.716 | 0.308 | 0.86 |
|
group | 0.110 | None | 0.500 | 1 | 1 | 2013 | 2015 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
group | 0.110 | None | 0.500 | 1 | 1 | 2015 | 2018 | ||||||||
|
cholinergic receptor muscarinic 3 | 0.464 | 0.885 | 0.99 |
|
disease | 0.410 | None | 0.500 | 1 | 1 | 2013 | 2019 | ||||||||
|
xyloside xylosyltransferase 1 | 0.780 | 0.231 | 1.3E-03 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2010 | 2012 | ||||||||
|
transmembrane protein 161B | 0.861 | 0.115 | 1.2E-05 |
|
disease | 0.110 | None | 0.500 | 1 | 2 | 2018 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2014 | 2016 | ||||||||
|
EPH receptor A5 | 0.626 | 0.615 | 7.3E-05 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2017 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2017 | 2018 | |||||||||
|
hepatocyte nuclear factor 4 gamma | 0.729 | 0.423 | 7.1E-02 |
|
disease | 0.120 | None | 0.500 | 1 | 1 | 2016 | 2018 | ||||||||
|
glutamate decarboxylase like 1 | 0.497 | 0.808 | 1.4E-21 |
|
disease | 0.110 | None | 0.500 | 1 | 14 | 2017 | 2019 |